Welcome to day 2 of the M2012 Conference, and to the Virtual Conference!
In this page you'll find talks from today's Plenary Sessions, just in case you missed them or want to revisit them. You can view the videos below, or see them all on Vimeo
Presentations
First presenter:
Milly Katana, Public Health Specialist, John Snow Incorporated, Uganda
Plenary session: Making access a reality for all those in need
In the opening plenary session of day 2 of the Conference, Milly Katana spoke about making access for microbicides a reality for all those who are affected, and in need of treatment. Milly gave the position of women, activists and advocates against HIV. Milly says: "I for one have lived in a generation of positioning HIV on the agenda of public discourse 20 years ago, and dealing with the stigma associated with HIV". Now, the third generation of advocates and activists positions prevention on the agenda of the response to HIV. Microbicides is crucial in this, as it benefits the protection of mothers, women and children.
There are no accompanying slides for this talk
Second presenter:
Kawango Agot, Impact Research and Development Organisation, Kenya
PLENARY SESSION:
Medical male circumcision in Kenya: From research to practice and lessons learnt
In the second plenary talk, Kawango Agot presented about the efficacy of medical male circumcision in the battle against HIV. Kawango applied the lessons that could be learnt from the roll out of medical male circumcision, to a microbicides roll out. Giving examples from several studies conducted across Africa, this presentation concludes with key challenges, opportunities, and lessons applicable from circumcision studies to the future of microbicide research.
Accompanying slides will be available shortly
Third presenter:
Helen Rees, Executive Director of Wits Reproductive Health and HIV Institute, South Africa
PLENARY SESSION:
Contraception and HIV
In the concluding plenary presentation of day 2 of the Conference, Helen Rees spoke about contraception and HIV. The use of contraception is one of public health's most powerful interventions. Contraceptive use reduces maternal mortality, improves infant and child outcomes and empowers women. For women using contraceptive methods in the context of significant HIV risk, there are some key questions that have formed the basis of an extensive research agenda over the past fifteen years. This presentation discusses these issues and the recommendations and potential impacts of research findings for individual women and for programmes are discussed as well.
Accompanying slides will be available shortly
